Clinical trial
Study Evaluating Genotypes Using Lucentis
NCT00474695 · University of Utah, Other · Terminated
Key facts
| NCT number | NCT00474695 |
|---|---|
| Title | Study Evaluating Genotypes Using Lucentis |
| Official title | VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis |
| Acronym | SEAGUL |
| Lead sponsor | University of Utah, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Age-Related Maculopathy |
| Intervention type | Drug |
| Interventions | Lucentis |
| Enrollment | 65 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 17, 2007 |
| Last update posted | Feb 11, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: